Metformin adherence and the risk of cardiovascular disease: a population-based cohort study.
Therapeutic advances in chronic disease（2023）
Abstract
This study revealed that metformin adherence in patients with T2DM who required a first-line treatment may reduce the risk of subsequent CVD. Despite the availability of numerous novel antiglycemic agents, metformin adherence by patients who require a combination of antiglycemic agents provides an additional benefit of CVD protection.
MoreTranslated text
Key words
cardiovascular disease,diabetes,metformin,myocardial infarction,stroke
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined